High prevalence of Transmitted HIV Drug Resistance Mutations in a cohort of newly diagnosed HIV-infected patients at entrance to care in the period from 2014 to 2015: the Croatian data

Oroz, Maja; Planinic, Ana; Židovec Lepej, Snježana; Begovac, Josip

Pregled bibliografske jedinice broj: 1031840

High prevalence of Transmitted HIV Drug Resistance Mutations in a cohort of newly diagnosed HIV- infected patients at entrance to care in the period from 2014 to 2015: the Croatian data

Oroz, Maja; Planinic, Ana; Židovec Lepej, Snježana; Begovac, Josip

High prevalence of Transmitted HIV Drug Resistance Mutations in a cohort of newly diagnosed HIV- infected patients at entrance to care in the period from 2014 to 2015: the Croatian data // Abstract book of the 16th EU Meeting on HIV&Hepatitis ; Reviews in Antiviral Therapy & Infectious Diseases, 2018
Rim, Italija, 2018. str. 72-72 (poster, međunarodna recenzija, sažetak, znanstveni)

CROSBI ID: 1031840 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
High prevalence of Transmitted HIV Drug Resistance Mutations in a cohort of newly diagnosed HIV- infected patients at entrance to care in the period from 2014 to 2015: the Croatian data

Autori
Oroz, Maja ; Planinic, Ana ; Židovec Lepej, Snježana ; Begovac, Josip

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstract book of the 16th EU Meeting on HIV&Hepatitis ; Reviews in Antiviral Therapy & Infectious Diseases, 2018 / - , 2018, 72-72

Skup
16th European Meeting on HIV & Hepatitis "Treatment Strategies & Antiviral Drug Resistance"

Mjesto i datum
Rim, Italija, 30.05.2018. - 01.06.2018

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
HIV-1 ; primarna rezistencija na antiretrovirusne lijekove
(HIV-1 ; primary drug resistance)

Sažetak
Croatia has a centralized system of HIV clinical care and all patients are treated at University Hospital for Infectious Diseases “Dr. Fran Mihaljevic”, Zagreb (UHID). Previous national study by Grgic et al. showed a high prevalence of transmitted drug resistance (TDR) of 21.6% (in the period 2006 to 2008), mainly attributed to the transmission clusters among MSM characterized by the presence of T215S mutation (1). In order to continue national TDR surveillance, we analyzed the prevalence of TDR mutations for the time period 2014-2015. Included were newly diagnosed, treatment-naive patients who entered clinical care at UHID during the study period.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

POVEZANOST RADA

Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"

Profili:

Josip Begovac (autor)